Andexxa
NDC Package 69853-0102-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Andexxa is a . Marketed by Alexion Pharmaceuticals, Inc., this product is identified by NDC 69853-0102 and is authorized under FDA application BLA125586.

Identification & Billing

NDC Package Code
69853-0102-1
Package Description
4 VIAL, SINGLE-USE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-USE
Product Code
69853-0102
11-Digit Billing Format
69853010201
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
1 EA

Clinical Specifications

Proprietary Name
Andexxa
Dosage Form
-

Regulatory & Marketing

Labeler Name
Alexion Pharmaceuticals, Inc.
FDA Application #
BLA125586
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
01-08-2019
End Marketing Date
11-30-2024
Listing Expiration
11-30-2024
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 69853-0102-1 identifies a specific commercial package of 4 vial, single-use in 1 carton / 20 ml in 1 vial, single-use of Andexxa, labeled by Alexion Pharmaceuticals, Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Alexion Pharmaceuticals, Inc. on January 08, 2019. The current certification is valid through November 30, 2024.

How is this Alexion Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 69853010201. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 1 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
69853-0102-1
11-Digit CMS (5-4-2)
69853-0102-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.